Medicago, Inc.

Medicago, Inc.

Medicago, Inc.

Overview
Date Founded

2006

Headquarters

1020, route de l'Église,bureau 600,Québec, QC G1V 3V9

Type of Company

Private

Employees (Worldwide)

501 - 1,000

Industries

Biotechnology
Medical Support Services
Hospitals & Patient Services

Company Description

Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.

Contact Data
Trying to get in touch with decision makers at Medicago, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Vice President, Scientific & Medical Affairs

Executive Vice President Operations

Vice President-Process Development

Vice President-Regulatory Affairs

Vice President-Research & Innovation

Vice President, Marketing & Business Development

Chief Financial Officer & US Site Manager

Board of Directors

Chief Executive Officer, President at Medicago USA, Inc.

President & Chief Executive Officer at Medicago, Inc.

Founder at Antibe Therapeutics, Inc.

Auditor at Mitsubishi Tanabe Pharma Corp.

Former Managing Executive Officer, Director, Chief Director of Childcare Medical Affairs & Manager of External Affairs at Mitsubishi Tanabe Pharma Corp.

Former Manager-Public Relations at Mitsubishi Tanabe Pharma Corp.

Director at Medicago, Inc.

Paths to Medicago, Inc.
Potential Connections via
Relationship Science
You
Medicago, Inc.
Recent Transactions
Details Hidden

Mitsubishi Tanabe Pharma Corp., Mitsubishi Chemical Holdings Corp. purchase Medicago, Inc.

Details Hidden

Medicago, Inc. issued CAD Units

Details Hidden

Medicago, Inc. issued CAD Units

Transaction Advisors
Auditor

Advised onMedicago, Inc. issued CAD Units

Underwriter

Advised onMedicago, Inc. issued CAD Subscription Receipts

Underwriter

Advised onMedicago, Inc. issued CAD Units

Attorney

Advised onMitsubishi Tanabe Pharma Corp., Mitsubishi Chemical Holdings Corp. purchase Medicago, Inc.

Legal Advisor

Advised onMitsubishi Tanabe Pharma Corp., Mitsubishi Chemical Holdings Corp. purchase Medicago, Inc.

Legal Advisor

Advised onMitsubishi Tanabe Pharma Corp., Mitsubishi Chemical Holdings Corp. purchase Medicago, Inc.

Key Stats and Financials As of
Market Capitalization
$303M
Total Enterprise Value
Earnings Per Share
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Medicago, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Medicago, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Medicago, Inc..